Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Xyotax enters phase III evaluation in ovarian cancer

July 31, 2002

DNA minor groove-binding antitumor agent with potential in refractory tumors

July 31, 2002

HDAC-inhibitory hydroxamates recently described in Roche patent

July 31, 2002

Liposomal TOP-53 may be associated with improved tolerance

July 31, 2002

SignalGene updates progress of SG-292

July 30, 2002

Clofarex enters trials in AML, ALL and solid tumors

July 30, 2002

Researchers at Aventis report the isolation and activity of klainetins

July 30, 2002

Novel steroid 17,20 lyase inhibitors in early development at Takeda

July 30, 2002

Synthetic MMP inhibitor Ro-28-2653 undergoes in vitro and in vivo testing

July 30, 2002

Arius and Oxford BioMedica to develop cancer immunotherapeutics

July 29, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...